In a development that has captured global attention, former U.S. President Joe Biden, 82, was diagnosed on May 16 with an aggressive form of prostate cancer, his personal office announced on May 18.
Key details from the statement include:
- Gleason score 9 (Grade Group 5): Indicates a more aggressive cancer type.
- Bone metastasis: The cancer has spread beyond the prostate.
- Hormone-sensitive: Offers a clearer path for effective treatment options.
The journey began when Biden experienced urinary symptoms, prompting his doctors to discover a small nodule on his prostate. "While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management," the statement read.
Having served as the oldest U.S. president from January 2021 to January 2025, Biden and his family are now reviewing treatment paths with his medical team, weighing options that could range from hormone therapy to targeted interventions designed to manage bone involvement.
For young leaders and global citizens, the news underscores the importance of early screening and awareness around prostate health—an issue that affects millions of men worldwide each year.
Stay tuned as we follow updates on Biden’s treatment plan and recovery journey, and explore what his diagnosis may mean for conversations around health, aging, and leadership on the world stage.
Reference(s):
cgtn.com
